Bioventus Inc. Contracts & Agreements
93 Contracts & Agreements
- Business Finance (29 contracts)
- Business Formation (6)
- Business Operations (11)
- Human Resources (22)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (19)
- Amendment No. 1 to the Stockholders Agreement by and among Bioventus Inc., Bioventus LLC and the Principal Stockholders dated as of June 19, 2024 (Filed With SEC on June 21, 2024)
- Form of Bioventus Inc. Inducement Award Option Agreement (Filed With SEC on December 21, 2023)
- Form of Bioventus Inc. Inducement Award Restricted Stock Unit Agreement (Filed With SEC on December 21, 2023)
- Employment Agreement between Robert E. Claypoole and Bioventus Inc., dated as of December 19, 2023 (Filed With SEC on December 21, 2023)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on June 9, 2023)
- Bioventus Inc. 2023 Retention Equity Award Plan (Filed With SEC on June 9, 2023)
- Asset Purchase Agreement, dated May 10, 2023, by and among Misonix, LLC, Solsys Medical, LLC, Bioventus LLC and LifeNet Health (Filed With SEC on May 16, 2023)
- Consulting Agreement between Alessandra Pavesio and Bioventus LLC, dated as of January 1, 2023 (Filed With SEC on May 16, 2023)
- Settlement Agreement by and among CartiHeal (2009) Ltd., Bioventus LLC, Elron Ventures Ltd., and certain other parties detailed therein, dated February 27, 2023 (Filed With SEC on May 16, 2023)
- Employment Agreement between Anthony P. Bihl III and Bioventus Inc., dated as of April 5, 2023 (Filed With SEC on April 11, 2023)
- Separation Agreement and Release between Kenneth Reali and Bioventus Inc., dated April 4, 2023 (Filed With SEC on April 5, 2023)
- Bioventus Inc. 2021 Equity Incentive Plan (Filed With SEC on August 12, 2022)
- Amendment No. 1 to Option and Equity Purchase Agreement, between the Company, CartiHeal (2009) Ltd. (CartiHeal), Elron Ventures Ltd. and ESOP Management and Trust Services Ltd.,... (Filed With SEC on June 22, 2022)
- Employment Agreement, dated February 14, 2022, between the Company and Mark Singleton (Filed With SEC on February 28, 2022)
- Lease Agreement, dated November 17, 2021, between Bioventus LLC and 7101 Goodlett Farms Parkway, LLC (Filed With SEC on November 22, 2021)
- Amendment No. 1 to Cre (Filed With SEC on November 10, 2021)
- Agreement and Plan of Merger, dated as of July 29, 2021, by and among Bioventus Inc., Oyster Merger Sub I, Inc., Oyster Merger Sub II, LLC and Misonix, Inc (Filed With SEC on July 29, 2021)
- Agreement and plan of merger, dated as of March 30, 2021, by and among Bioventus LLC, Bioness Inc., Perseus Intermediate, Inc., Perseus Merger Sub, Inc., Alfred E. Mann Living... (Filed With SEC on March 31, 2021)
- Description of Securities (Filed With SEC on March 26, 2021)
- Settlement Agreement, dated as of February 22, 2021, by and between the United States of America, acting through the United States Attorneys Office for the Middle District of... (Filed With SEC on March 26, 2021)
- Stockholders Agreement, dated February 16, 2021, by and among Bioventus Inc., Bioventus LLC and the Principal Stockholders (Filed With SEC on February 17, 2021)
- Registration Rights Agreement, dated February 16, 2021, by and among Bioventus Inc. and the Original LLC Owners (Filed With SEC on February 17, 2021)
- Tax Receivable Agreement, dated as of February 16, 2021, by and among Bioventus Inc., Bioventus LLC and its Members (Filed With SEC on February 17, 2021)
- Second Amended and Restated Limited Liability Company Agreement of Bioventus LLC, dated as of February 16, 2021 (Filed With SEC on February 17, 2021)
- Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Kenneth Reali (Filed With SEC on February 10, 2021)
- Option Forfeiture Letter, dated February 3, 2021, by and between Bioventus LLC and Kenneth Reali (Filed With SEC on February 10, 2021)
- Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Alessandra Pavesio (Filed With SEC on February 10, 2021)
- Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Anthony DAdamio (Filed With SEC on February 10, 2021)
- Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and John E. Nosenzo (Filed With SEC on February 10, 2021)
- Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Gregory O. Anglum (Filed With SEC on February 10, 2021)
- Bioventus Inc. Non-Employee Director Compensation Policy (Filed With SEC on February 10, 2021)
- Assignment and Assumption Agreement, dated February 9, 2021, by and between Bioventus Inc. and Bioventus LLC (Filed With SEC on February 10, 2021)
- Amendment and Termination of the Bioventus Stock Plan, dated as of February 9, 2021 (Filed With SEC on February 10, 2021)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on February 10, 2021)
- Form of Stock Option Award Grant Notice and Stock Option Agreement (Filed With SEC on February 10, 2021)
- Form of 2021 Incentive Award Plan (Filed With SEC on February 10, 2021)
- Form of Stockholders Agreement, to be effective upon the closing of this offering (Filed With SEC on February 10, 2021)
- Form of Second Amended and Restated Bioventus LLC Limited Liability Company Agreement, to be effective upon the closing of this offering (Filed With SEC on February 10, 2021)
- Form of Registration Rights Agreement, to be effective upon the closing of this offering (Filed With SEC on February 10, 2021)
- Amendment No. 2 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2020, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Filed With SEC on February 4, 2021)
- Form of Registration Rights Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
- Form of Tax Receivable Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 4, 2021)
- Form of Indemnification Agreement (Filed With SEC on February 4, 2021)
- Form of 2021 Incentive Award Plan (Filed With SEC on February 4, 2021)
- Form of 2021 Employee Stock Purchase Plan (Filed With SEC on February 4, 2021)
- Bioventus LLC Management Incentive Plan (Filed With SEC on February 4, 2021)
- Form of Stockholders Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
- Form of Second Amended and Restated Bioventus LLC Limited Liability Company Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
- Amended and Restated Limited Liability Company Agreement of Bioventus LLC, as amended, as currently in effect (Filed With SEC on January 20, 2021)
- Specimen Stock Certificate evidencing the shares of Class A common stock (Filed With SEC on January 20, 2021)
- Amended and Restated License Agreement, dated as of December 9, 2016, by and between Bioventus LLC, Q-Med AB and Nestl Skin Health S.A (Filed With SEC on January 20, 2021)
- Amended and Restated Supply Agreement, dated as of December 9, 2016, by and between Bioventus LLC and Q-Med AB (Filed With SEC on January 20, 2021)
- Exclusive License, Supply and Distribution Agreement, dated as of February 9, 2016, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Filed With SEC on January 20, 2021)
- Amendment No. 1 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2018, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Filed With SEC on January 20, 2021)
- Amended and Restated Exclusive Distribution Agreement No. 2 by and between Seikagaku Corporation and Bioventus LLC, effective December 22, 2020 (Filed With SEC on January 20, 2021)
- Option and Equity Purchase Agreement, dated as of July 15, 2020, among Bioventus LLC, CartiHeal (2009) Ltd., the Securityholders set forth on Schedule 1.01(a) thereto, each of the... (Filed With SEC on January 20, 2021)
- AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SEIKAGAKU CORPORATION AND BIOVENTUS LLC RESTATED AS OF MAY 4 , 2012 AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION... (Filed With SEC on July 27, 2016)
- BIOVENTUS LLC SECONDAMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of [], 2016 (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. 2016INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. 2016INCENTIVE AWARD PLAN DIRECTOR RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. 2016INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. 2016INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. 2016INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on July 19, 2016)
- PROPRIETARY INFORMATION, INVENTIONS, NON-SOLICITATION, AND NON-COMPETITION AGREEMENT (Filed With SEC on July 19, 2016)
- PROPRIETARY INFORMATION, INVENTIONS, NON-SOLICITATION AND NON-COMPETITION AGREEMENT (Filed With SEC on July 19, 2016)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUSLLC AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT dated as of May 4, 2012 among SMITH &NEPHEW, INC., BELUGA I, INC., BELUGA II, INC., BELUGA III, INC., BELUGA... (Filed With SEC on July 19, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 19, 2016)
- TAX RECEIVABLE AGREEMENT by and among BIOVENTUS INC. BIOVENTUS LLC and the MEMBERS (as defined herein) Dated as of [], 2016 CONTENTS (Filed With SEC on July 19, 2016)
- Bioventus Inc. [] Sharesof Class A Common Stock Underwriting Agreement (Filed With SEC on July 19, 2016)
- BIOVENTUS LLC PHANTOMPROFITS INTERESTS PLAN AWARD AGREEMENT (Filed With SEC on July 19, 2016)
- STOCKHOLDERS AGREEMENT (Filed With SEC on July 19, 2016)
- FIRST LIEN CREDIT AGREEMENT among BIOVENTUS LLC, as Borrower, The Several Lendersfrom Time to Time Parties Hereto, HSBC BANK USA, NATIONAL ASSOCIATION, CITIZENS BANK, N.A. and... (Filed With SEC on July 19, 2016)
- SECOND LIEN CREDIT AGREEMENT among BIOVENTUS LLC, as Borrower, The Several Lendersfrom Time to Time Parties Hereto, JPMORGAN CHASE BANK, N.A, as Syndication Agent and CITIZENS... (Filed With SEC on July 19, 2016)
- AMENDMENT NO. 1 TO THE FIRST LIEN CREDIT AGREEMENT (Filed With SEC on July 19, 2016)
- AMENDMENT NO. 1 TO THE SECOND LIEN CREDIT AGREEMENT (Filed With SEC on July 19, 2016)
- AMENDED AND RESTATED DISTRIBUTION AGREEMENT BY AND BETWEEN BIOVENTUS LLC AND SEIKAGAKU CORPORATION DATED AS OF JUNE 30, 2016 AMENDED AND RESTATED DISTRIBUTION AGREEMENT (Filed With SEC on July 19, 2016)
- AMENDMENT AND RESTATEMENT AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUS LLC MANAGEMENT INCENTIVE PLAN DATED AS OF MAY 4, 2012 (Filed With SEC on July 19, 2016)
- BIOVENTUS LLC PHANTOMPROFITS INTERESTS PLAN AS AMENDED AND RESTATED DECEMBER 30, 2015 (Filed With SEC on July 19, 2016)
- BIOVENTUS LLC PHANTOMPROFITS INTERESTS PLAN AWARD AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE (Filed With SEC on July 19, 2016)
- PHANTOM AWARD (EXECUTIVE) /TERMINATION BIOVENTUS LLC PHANTOMPROFITS INTERESTS PLAN AWARD AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUS LLC MANAGEMENT INCENTIVE PLAN AWARD AGREEMENT (Filed With SEC on July 19, 2016)
- BIOVENTUS LLC PHANTOMPROFITS INTERESTS PLAN AWARD AGREEMENT (Filed With SEC on July 19, 2016)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on July 19, 2016)
- AMENDMENT AND TERMINATION OF THE BIOVENTUS LLC AMENDED AND RESTATED PHANTOM PROFITS INTERESTS PLAN July [ ], 2016 (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. DIRECTOR STOCK OWNERSHIP POLICY (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on July 19, 2016)
- BIOVENTUS INC. SENIOREXECUTIVE INCENTIVE BONUS PLAN (Filed With SEC on July 19, 2016)
- Bioventus Inc. 4721 EmperorBoulevard, Suite 100 Durham, NC 27703 (Filed With SEC on June 30, 2016)
- AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SEIKAGAKU CORPORATION AND BIOVENTUS LLC RESTATED AS OF MAY 4 , 2012 AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION... (Filed With SEC on June 30, 2016)
